Adult bacteremic pneumococcal pneumonia acquired in the community. A prospective study on 101 patients

Jorge H Gentile1, Mónica D Sparo, María E Mercapide

  • 1Servicio de Infectología, Laboratorio de Microbiología, Hospital R. Santamarina, Tandil. jorgeg@poraire.net.ar

Medicina
|April 4, 2003
PubMed

Insights

Bacteremic pneumococcal pneumonia (BPP) affects adults, with higher mortality in older patients and those with heart failure. Penicillin-resistant Streptococcus pneumoniae remains uncommon in this setting.

Area of Science:

  • Infectious Diseases
  • Pulmonology
  • Microbiology

Background:

  • Bacteremic pneumococcal pneumonia (BPP) is a significant cause of morbidity and mortality.
  • Understanding its epidemiological and clinical features is crucial for effective management.

Purpose of the Study:

  • To describe the incidence, clinical, radiographic, and microbiological characteristics of BPP.
  • To identify factors associated with mortality in BPP patients.

Main Methods:

  • Prospective evaluation of 101 adult patients with BPP.
  • Data collection included demographics, clinical presentation, radiographic findings, microbiological results, and outcomes.
  • Statistical analysis to compare survivors and non-survivors.

Main Results:

  • Incidence of BPP was 2.8 cases per 1000 admissions.
  • Common symptoms included fever, cough, and chest pain; 44% had extrapulmonary manifestations.
  • Mortality was 11.8%, increasing with age. Congestive heart failure (CHF) was more frequent in non-survivors.
  • Lobar radiographic patterns were seen in survivors, diffuse patterns in non-survivors.
  • Penicillin-resistant Streptococcus pneumoniae was rare (3%).

Conclusions:

  • BPP incidence is comparable to international data.
  • Clinical and radiographic differences exist between survivors and non-survivors.
  • Penicillin resistance in S. pneumoniae is currently an infrequent issue in this region.

Related Concept Videos

Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...